Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-19

FDA Approved: POTASSIUM CHLORIDE EXTENDED RELEASE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved an original ANDA for Potassium Chloride Extended Release, a generic potassium chloride product from Rising Pharma Holdings, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Potassium Chloride Extended Release (Potassium chloride)

Snippet

ORIG AP for POTASSIUM CHLORIDE EXTENDED RELEASE (POTASSIUM CHLORIDE)